#161696

Anti-B2M monoclonal antibody [GRH1]

Cat. #161696

Anti-B2M monoclonal antibody [GRH1]

Cat. #: 161696

Sub-type: Primary antibody

Target: Beta-2-microglobulin

Class: Monoclonal

Application: FACS; IHC; ELISA; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Dr. Francisco Ruíz-Cabello Osuna,Dr. Miguel Ángel López-Nevot and Federico Garrido Torres-Puchol,

Institute: Virgen de las Nieves University Hospital, The Andalusian Health Service

Primary Citation: Perea et al. 2017. Int J Cancer. 140(4):888-899. PMID: 27785783

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-B2M monoclonal antibody [GRH1]
  • Clone: GRH1
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Molecular weight: 12 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS; IHC; ELISA; WB
  • Description: Beta-2-microglobulin (B2M) is part of the histocompatibility antigens class I, HLA-ABC, forming a non-covalently bound complex with them. It is expressed in most cells in the body, with very low or undetectable levels in neurons and spermatozoa.
  • Immunogen: B-ALL cells
  • Isotype: IgG1
  • Recommended controls: B-Lymphocytes, macrophages

Target Details

  • Target: Beta-2-microglobulin
  • Target alternate names: B2M
  • Molecular weight: 12 kDa

Applications

  • Application: FACS; IHC; ELISA; WB

Handling

  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • Perea et al. 2017. Int J Cancer. 140(4):888-899. PMID: 27785783
  • B del Campo. 2014. Int J Cancer. 134(1):102-113. PMID: 23784959